Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19.

J Am Coll Cardiol · 2023 · PMC9987252 · PMID 36889611

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among noncritically ill patients hospitalized with COVID-19, the difference between groups in the incidence of the 30-day primary outcome (a composite of all-cause mortality, requirement for ICU level of care, systemic thromboembolism, or ischemic stroke) in patients treated with therapeutic-dose anticoagulation compared with prophylactic-dose anticoagulation did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.